Too Late to Vaccinate? The Incremental Benefits and Cost-effectiveness of a Delayed Catch-up Program Using the 4-Valent Human Papillomavirus Vaccine in Norway
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.